Cytokinetics Inc (CYTK): Mark Lampert’s Biotechnology Value Fund Loads Up On More Shares

Page 3 of 14

Page 3 of 14 SEC Filing

(1)  Excludes 225,379 shares of Common Stock issuable upon the exercise of certain Warrants (defined below). The Warrants may not be exercised if, after such exercise, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, more than 9.98% of the number of shares of Common Stock then issued and outstanding.

Follow Cytokinetics Inc (NASDAQ:CYTK)

Page 3 of 14